(Q41937102)

14 October 2017

title

Chloroquine Retinopathy. Investigation of Discrepancy Between Dark Adaptation and Electroretinographic Findings in Advanced Stages (English)

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

1 June 2023

0 references

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

1 June 2023

author name string

A. E. Krill

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5547534

1 June 2023

A. M. Potts

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5547534

1 June 2023

C. E. Johanson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5547534

1 June 2023

language of work or name

English

0 references

publication date

1 February 1971

1 reference

full work available at URL

14 October 2017

https://api.elsevier.com/content/article/PII:0002939471901309?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

https://api.elsevier.com/content/article/PII:0002939471901309?httpAccept=text/plain

1 June 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

American Journal of Ophthalmology

1 June 2023

published in

1 reference

14 October 2017

volume

71

1 reference

14 October 2017

issue

2

1 reference

14 October 2017

page(s)

530-543

1 reference

Chloroquine retinopathy; a report of eight cases with ERG and dark-adaptation findings

14 October 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

EARLY CHLOROQUINE RETINOPATHY: CLINICAL AND FUNCTIONAL FINDINGS.

1 June 2023

2

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

Chloroquine retinopathy. Early detection by retinal threshold test

1 June 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

THE EOG IN CHLOROQUINE AND OTHER RETINOPATHIES.

1 June 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

Ocular damage in chloroquine therapy

1 June 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

Retinopathy after nivaquine treatment

1 June 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

Three cases of chloroquine retinopathy. A follow-up investigation

1 June 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

Electro-oculogram findings in patients treated with antimalarial drugs

1 June 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

Electrophysiological abnormalities in pigmentary degenerations of the retina. Assessment of value and basis

1 June 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

OCULAR LESIONS AFTER TREATMENT WITH CHLOROQUINE.

1 June 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

Automatic intensity control in testing dark adaptation

1 June 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

The Electroretinogram in Albinos and Carriers of the Ocular Albino Trait

1 June 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

1 June 2023

Flecked retina syndrome

18

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

New clinical test of retinal function based upon the standing potential of the eye.

1 June 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

Observations of carriers of X-chromosomal-linked chorioretinal degenerations. Do these support the "inactivation hypothesis"?

1 June 2023

21

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

An absolute threshold defect in the inferior retina

1 June 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

Rate of dark adaptation and regional threshold gradient of the dark-adapted eye; physiologic and clinical studies

1 June 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

The threshold gradients of the rods and the cones; in the dark-adapted and in the partially light-adapted eye

1 June 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

THE NATURE OF DARK ADAPTATION

1 June 2023

25

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

Nervous mechanisms and dark-adaptation

1 June 2023

26

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

Visual Purple Level and the Course of Dark Adaptation

1 June 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

A static perimetric technique believed to test receptive field properties. 3. Clinical trials

1 June 2023

29

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

Foveal simultaneous brightness contrast as a function of inducing-and test-field luminances

1 June 2023

30

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

HISTOPATHOLOGY OF CHLOROQUINE RETINAL TOXICITY.

1 June 2023

31

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

Chloroquine ocular toxicity

1 June 2023

32

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

Incidence of chloroquine retinopathy

1 June 2023

33

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

Ocular toxicity of antimalarial drugs. Long-term follow-up

1 June 2023

34

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

Delayed Onset of Chloroquine Retinopathy

1 June 2023

36

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

THE EFFECT OF A SYNTHETIC ANTIMALARIAL (AMODIAQUINE) ON THE RETINA

1 June 2023

38

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

Electro-oculogram findings in patients treated with antimalarial drugs

1 June 2023

39

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

Ocular abnormalities in patients treated with synthetic antimalarial drugs

1 June 2023

40

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

THE PATHOLOGY OF CHLOROQUINE RETINOPATHY.

1 June 2023

41

1 reference

https://api.crossref.org/works/10.1016/0002-9394(71)90130-9

1 June 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=5547534

1 June 2023

1 reference